Prevalence of Darunavir Resistance in the United States from 2010 to 2017

The emergence and transmission of antiretroviral drug resistance have been and remain a concern among people living with human immunodeficiency virus (HIV)-1 infection. The protease inhibitor (PI) darunavir has been approved for use in the United States for more than 10 years and has demonstrated a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Kimberley, Stewart, Lisa, Whitcomb, Jeannette M., Yang, Dongmei, Nettles, Richard E., Lathouwers, Erkki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306664/
https://www.ncbi.nlm.nih.gov/pubmed/30148406
http://dx.doi.org/10.1089/aid.2018.0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306664/
https://www.ncbi.nlm.nih.gov/pubmed/30148406
http://dx.doi.org/10.1089/aid.2018.0100

Ejemplares similares